Brinsupri
Payments companies reported to CMS as associated with Brinsupri. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Brinsupri, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Brinsupri
These are the largest totals companies reported as associated with Brinsupri. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joseph Khabbaza | Akron, OH | Pulmonary Disease | $9,191.36 |
| Robert Jasmer | Burlingame, CA | Pulmonary Disease | $3,846.76 |
| Julie Biller | Milwaukee, WI | Pulmonary Disease | $2,942.52 |
| Rayen Ayoub Chakra | Panama City, FL | Infectious Disease | $2,053.34 |
| Ashlee Russo | Youngstown, OH | Pulmonary Disease | $1,825.44 |
| Juzar Ali | New Orleans, LA | Pulmonary Disease | $1,633.18 |
| Ryan Reber | Wynnewood, PA | Pulmonary Disease | $1,597.16 |
| Abhijit Raval | Anderson, SC | Pulmonary Disease | $1,528.42 |
| Jered Weinstock | Anchorage, AK | Pediatric Pulmonology | $1,136.06 |
| Matthew Abbott | Oklahoma City, OK | Pulmonary Disease | $495.40 |
Prescribed Brinsupri?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.